Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$327M Buy
928,500
+102,500
+12% +$36.5M 0.04% 277
2025
Q4
$270M Sell
826,000
-280,900
-25% -$89.1M 0.04% 282
2025
Q3
$312M Buy
1,106,900
+263,100
+31% +$76.3M 0.05% 260
2025
Q2
$236M Sell
843,800
-421,200
-33% -$119M 0.05% 249
2025
Q1
$394M Buy
1,265,000
+585,600
+86% +$173M 0.1% 127
2024
Q4
$177M Sell
679,400
-401,900
-37% -$119M 0.04% 279
2024
Q3
$348M Buy
1,081,300
+562,500
+108% +$184M 0.08% 135
2024
Q2
$162M Sell
518,800
-79,100
-13% -$23.2M 0.04% 254
2024
Q1
$170M Buy
597,900
+93,500
+19% +$27.4M 0.04% 251
2023
Q4
$145M Buy
504,400
+118,200
+31% +$32.2M 0.04% 288
2023
Q3
$104M Sell
386,200
-1,277,500
-77% -$319M 0.03% 311
2023
Q2
$369M Buy
1,663,700
+1,428,600
+608% +$331M 0.12% 77
2023
Q1
$56.8M Sell
235,100
-110,800
-32% -$27.2M 0.02% 473
2022
Q4
$90.8M Buy
345,900
+6,600
+2% +$1.77M 0.04% 326
2022
Q3
$76.5M Sell
339,300
-892,200
-72% -$216M 0.03% 353
2022
Q2
$300M Buy
1,231,500
+36,700
+3% +$8.99M 0.13% 83
2022
Q1
$289M Buy
1,194,800
+893,000
+296% +$205M 0.09% 121
2021
Q4
$67.9M Sell
301,800
-2,300
-0.8% -$485K 0.02% 519
2021
Q3
$64.7M Sell
304,100
-528,500
-63% -$122M 0.02% 496
2021
Q2
$203M Buy
832,600
+700,000
+528% +$172M 0.08% 166
2021
Q1
$33M Sell
132,600
-130,100
-50% -$31M 0.02% 650
2020
Q4
$60.4M Sell
262,700
-113,700
-30% -$26.2M 0.03% 397
2020
Q3
$95.7M Buy
376,400
+146,900
+64% +$36.4M 0.06% 228
2020
Q2
$54.1M Buy
229,500
+162,300
+242% +$37M 0.04% 332
2020
Q1
$13.6M Buy
67,200
+14,900
+28% +$3.25M 0.01% 609
2019
Q4
$12.6M Sell
52,300
-33,300
-39% -$7.34M 0.02% 540
2019
Q3
$16.6M Sell
85,600
-19,400
-18% -$3.72M 0.03% 410
2019
Q2
$19.4M Sell
105,000
-9,000
-8% -$1.61M 0.03% 380
2019
Q1
$21.7M Buy
114,000
+26,700
+31% +$5.1M 0.04% 395
2018
Q4
$17M Buy
87,300
+18,600
+27% +$3.63M 0.04% 373
2018
Q3
$14.2M Buy
68,700
+13,700
+25% +$2.7M 0.03% 439
2018
Q2
$10.2M Sell
55,000
-29,700
-35% -$5.25M 0.02% 606
2018
Q1
$14.4M Buy
84,700
+19,500
+30% +$3.58M 0.04% 406
2017
Q4
$11.3M Sell
65,200
-87,900
-57% -$15.6M 0.03% 461
2017
Q3
$28.5M Buy
153,100
+132,300
+636% +$23.4M 0.09% 198
2017
Q2
$3.58M Sell
20,800
-71,600
-77% -$11.6M 0.01% 999
2017
Q1
$15.2M Buy
92,400
+8,800
+11% +$1.46M 0.07% 254
2016
Q4
$12.2M Sell
83,600
-146,400
-64% -$22M 0.05% 290
2016
Q3
$38.4M Buy
230,000
+177,400
+337% +$30M 0.18% 103
2016
Q2
$8M Sell
52,600
-27,400
-34% -$4.26M 0.04% 416
2016
Q1
$12M Sell
80,000
-77,300
-49% -$11.5M 0.07% 256
2015
Q4
$25.5M Buy
157,300
+73,500
+88% +$11.6M 0.16% 113
2015
Q3
$11.6M Buy
83,800
+62,600
+295% +$9.87M 0.07% 225
2015
Q2
$3.25M Buy
21,200
+400
+2% +$64.1K 0.02% 699
2015
Q1
$3.33M Buy
20,800
+16,400
+373% +$2.58M 0.03% 578
2014
Q4
$701K Buy
+4,400
New +$686K 0.01% 1272

Other funds holding AMGN

Jane Street's AMGN Position: Q1 2026 in Review

Jane Street increased its Amgen (AMGN) stake by 249% in Q1 2026, buying an estimated $28.2M and bringing the position to 110,665 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #1225.

Jane Street first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $133M in Q3 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Jane Street held 110,665 shares of Amgen worth $38.9M as of Q1 2026.
  • Jane Street bought 78,976 Amgen shares in Q1 2026, an estimated $28.2M.
  • Amgen made up 0.01% of Jane Street's portfolio in Q1 2026, its #1225 holding.
  • Jane Street first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Jane Street's Amgen position peaked at $133M in Q3 2023.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.